Update shared on15 Aug 2025
Fair value Decreased 31%A sharp decline in net profit margin alongside a rising future P/E multiple suggests deteriorating profitability and richer valuation, prompting analysts to significantly lower Luminar Technologies’ fair value from $4.33 to $3.00.
What's in the News
- Company expects Q3 2025 revenue of $17 million to $19 million.
- Fiscal Year 2025 revenue guidance lowered to $67 million to $74 million, citing reduced shipments and winding down of non-core contracts.
- Filed a follow-on equity offering of 1.6 million common shares at $3.32 per share, raising approximately $5.3 million.
- Stockholders ratified KPMG LLP as independent auditor for fiscal year ending December 31, 2025.
- Added to multiple Russell indices, including Microcap, 3000E, Value, and Growth benchmarks.
Valuation Changes
Summary of Valuation Changes for Luminar Technologies
- The Consensus Analyst Price Target has significantly fallen from $4.33 to $3.00.
- The Future P/E for Luminar Technologies has significantly risen from 20.81x to 26.62x.
- The Net Profit Margin for Luminar Technologies has significantly fallen from 5.33% to 4.25%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.